FDA Gives Teva Go-Ahead on Asthma Drug – http://hamodia.com


The Inquisitr

FDA Gives Teva Go-Ahead on Asthma Drug
http://hamodia.com
YERUSHALAYIM – The U.S. Food and Drug Administration (FDA) has announced approval of a new asthma treatment developed by the Israeli-based firm Teva, Globes reported on Sunday. CINQAIR injection for severe asthma sufferers is taken once every …
FDA approves Cinqair to treat severe asthmaFDA.gov
Asthma Attacks Face Newly Approved Super Treatment 'Cinqair'The Inquisitr
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
MedPage Today –UPI.com
all 77 news articles »

View full post on asthma – Google News

Roflumilast Gets the Go-Ahead for Patients with Asthma-COPD Overlap Syndrome – MD Magazine

Roflumilast Gets the Go-Ahead for Patients with Asthma-COPD Overlap Syndrome
MD Magazine
V. Beloglazov, from the Medical Academy named after S. I. Georgievsky in Russia, and colleagues studied the effects of roflumilast in patients with ACOS and presented the findings in a poster session at the 2015 American College of Allergy, Asthma, and …

View full post on asthma – Google News